VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 75 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,022,438 | -33.5% | 35,003 | -53.3% | 0.05% | -40.4% |
| Q3 2022 | $1,538,000 | +26.1% | 75,003 | -28.9% | 0.09% | +25.4% |
| Q2 2022 | $1,220,000 | -37.4% | 105,460 | 0.0% | 0.07% | +12.7% |
| Q1 2022 | $1,950,000 | -5.9% | 105,460 | +0.6% | 0.06% | -16.0% |
| Q4 2021 | $2,073,000 | +116.8% | 104,860 | +80.5% | 0.08% | +158.6% |
| Q3 2021 | $956,000 | – | 58,096 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,696,340 | $55,302,000 | 8.89% |
| TCG Crossover Management, LLC | 1,164,000 | $23,874,000 | 7.16% |
| VR Adviser, LLC | 2,130,308 | $43,693,000 | 6.74% |
| Fairmount Funds Management LLC | 1,369,623 | $28,091,000 | 4.94% |
| Paradigm Biocapital Advisors LP | 1,636,211 | $33,559,000 | 4.47% |
| Kynam Capital Management, LP | 1,000,000 | $20,510,000 | 4.32% |
| Vivo Capital, LLC | 1,660,019 | $34,047,000 | 3.76% |
| ACUTA CAPITAL PARTNERS, LLC | 362,735 | $7,440,000 | 3.20% |
| Ghost Tree Capital, LLC | 535,000 | $10,973,000 | 3.08% |
| Logos Global Management LP | 1,000,000 | $20,510,000 | 2.52% |